Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy

Clinical trial NCT02153125 · UNKNOWN

Trial details

NCT number: NCT02153125
Sponsor: Tel-Aviv Sourasky Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Central Serous Chorioretinopathy

Start date: 2014-04-01
Primary completion: 2015-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.